Abstract
Fourteen years after transplantation into the striatum of an individual with Parkinson's disease, grafted nigral neurons were found to have Lewy body–like inclusions that stained positively for α-synuclein and ubiquitin and to have reduced immunostaining for dopamine transporter. These pathological changes suggest that Parkinson's disease is an ongoing process that can affect grafted cells in the striatum in a manner similar to host dopamine neurons in the substantia nigra. These findings have implications for cell-based therapies and for understanding the cause of Parkinson's disease.
Access options
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
-
1
Olanow, C.W. et al. Ann. Neurol. 54, 403–414 (2003).
-
2
Freed, C.R. et al. N. Engl. J. Med. 344, 710–719 (2001).
-
3
Sawle, G.V. et al. Ann. Neurol. 31, 166–173 (1992).
-
4
Piccini, P. et al. Nat. Neurosci. 2, 1137–1140 (1999).
-
5
Kordower, J.H. et al. N. Engl. J. Med. 332, 1118–1124 (1995).
-
6
Kordower, J.H. et al. J. Comp. Neurol. 370, 203–230 (1996).
-
7
Kordower, J.H. et al. Cell Transplant. 6, 213–219 (1997).
-
8
Mendez, I. et al. Brain 128, 1498–1510 (2005).
-
9
Braak, H. et al. Neurobiol. Aging 24, 197–211 (2003).
-
10
Chu, Y. & Kordower, J.H. Neurobiol. Dis. 25, 134–149 (2007).
-
11
Olanow, C.W. et al. Lancet Neurol. 3, 496–503 (2004).
Acknowledgements
We would like to thank G. Folino for histological assistance.
Author information
Affiliations
Contributions
J.H.K. and Y.C. performed the histological analysis. R.A.H. performed the clinical assessments. T.B.F. did brain ascertainment. J.H.K., R.A.H., T.B.F. and C.W.O. wrote the manuscript. C.W.O., T.B.F. and J.H.K. designed the original open label transplant trial. T.B.F. and C.W.O. implemented the original clinical transplant trial.
Corresponding author
Ethics declarations
Competing interests
J.H.K. is a consultant for Ceregene, Inc., Brainstorm, Inc. and Nupathe, Inc. C.W.O. is a consultant for Ceregene, Inc. These companies could benefit from the results of this study.
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1 and 2 (PDF 2618 kb)
Rights and permissions
About this article
Cite this article
Kordower, J., Chu, Y., Hauser, R. et al. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14, 504–506 (2008). https://doi.org/10.1038/nm1747
Received:
Accepted:
Published:
Issue Date:
Further reading
-
Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
Journal of Movement Disorders (2020)
-
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology
Journal of Medical Genetics (2020)
-
Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease Patients
Frontiers in Cellular Neuroscience (2020)
-
Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases
Movement Disorders (2020)
-
Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
Translational Neurodegeneration (2020)